{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Longeveron Inc."},"Symbol":{"label":"Symbol","value":"LGVN"},"Address":{"label":"Address","value":"1951 NW 7TH AVENUE,SUITE 520, MIAMI, Florida, 33136, United States"},"Phone":{"label":"Phone","value":"+1 305 909-0840"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS)."},"CompanyUrl":{"label":"Company Url","value":"https://www.longeveron.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Brian Rash","title":"Vice President-Research & Discovery"},{"name":"Joshua M. Hare","title":"Chairman & Chief Scientific Officer"},{"name":"Kevin N. Ramdas","title":"Director-Clinical Operations"},{"name":"Mohamed Waâ€™el Ahmed Hashad","title":"Chief Executive Officer & Director"},{"name":"Nataliya Agafonova","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}